Abstract

The combined use of microarray technologies and bioinformatics analysis has improved our understanding of biological complexity of multiple myeloma (MM). In contrast, the application of the same technology in the attempt to predict clinical outcome has been less successful with the identification of heterogeneous molecular signatures. Herein, we have reconstructed gene regulatory networks in a panel of 1,883 samples from MM patients derived from publicly available gene expression sets, to allow the identification of robust and reproducible signatures associated with poor prognosis across independent data sets. Gene regulatory networks were reconstructed by using Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) and microarray data from seven MM data sets. Critical analysis of network components was applied to identify genes playing an essential role in transcriptional networks, which are conserved between data sets. Network critical analysis revealed that (i) CCND1 and CCND2 were the most critical genes; (ii) CCND2, AIF1, and BLNK had the largest number of connections shared among the data sets; (iii) robust gene signatures with prognostic power were derived from the most critical transcripts and from shared primary neighbors of the most connected nodes. Specifically, a critical-gene model, comprising FAM53B, KIF21B, WHSC1, and TMPO, and a neighbor-gene model, comprising BLNK shared neighbors CSGALNACT1 and SLC7A7, predicted survival in all data sets with follow-up information. The reconstruction of gene regulatory networks in a large panel of MM tumors defined robust and reproducible signatures with prognostic importance, and may lead to identify novel molecular mechanisms central to MM biology.

Highlights

  • In the past decade, a large amount of whole-genome transcriptional profiling data have been generated for almost all tumor types, among which multiple myeloma (MM) is characterized by one of the largest publicly avail-Authors' Affiliations: 1Department of Medical Sciences, University of Milan and Hematology 1, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; 2Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy; and 3Section of HaematoOncology, The Institute of Cancer Research, Royal Cancer Hospital, London, United KingdomNote: Supplementary data for this article are available at Clinical Cancer Research Online.L

  • Network critical analysis revealed that (i) CCND1 and CCND2 were the most critical genes; (ii) CCND2, AIF1, and BLNK had the largest number of connections shared among the data sets; (iii) robust gene signatures with prognostic power were derived from the most critical transcripts and from shared primary neighbors of the most connected nodes

  • Because the critical analysis of network components was developed for genecentered data, in those 2 data sets we assigned a unique value to all Entrez Gene IDs represented by multiple probe sets

Read more

Summary

Introduction

A large amount of whole-genome transcriptional profiling data have been generated for almost all tumor types, among which multiple myeloma (MM) is characterized by one of the largest publicly avail-. The skepticism about reliability and reproducibility of gene signatures for prognostic marker discovery stems from the complexity of microarray data, the limited number of samples analyzed, and the computational approach used. These limitations can be overcome by the integration of multiple, independently generated data sets and their analysis, using methods that allow the reverse engineering and reconstruction of regulatory networks

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.